This PDX model has been established from an ER+ primary breast cancer [12] and has been rendered resistant to tamoxifen in mice, through long-term in vivo treatment and re-engraftment of xenograft that showed acquired resistance to tamoxifen, as previously described [13]. The gene discussed is ESR1; the disease is breast carcinoma.